IXI vs. C4XD, DDDD, FUM, OKYO, SAR, AOR, OPTI, AREC, POLB, and RLM
Should you be buying IXICO stock or one of its competitors? The main competitors of IXICO include C4X Discovery (C4XD), 4D pharma (DDDD), Futura Medical (FUM), OKYO Pharma (OKYO), Sareum (SAR), AorTech International (AOR), OptiBiotix Health (OPTI), Arecor Therapeutics (AREC), Poolbeg Pharma (POLB), and Realm Therapeutics (RLM). These companies are all part of the "biotechnology" industry.
IXICO vs.
C4X Discovery (LON:C4XD) and IXICO (LON:IXI) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their community ranking, earnings, valuation, media sentiment, analyst recommendations, risk, dividends, institutional ownership and profitability.
52.1% of C4X Discovery shares are owned by institutional investors. Comparatively, 56.0% of IXICO shares are owned by institutional investors. 27.1% of C4X Discovery shares are owned by company insiders. Comparatively, 30.3% of IXICO shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
C4X Discovery has higher revenue and earnings than IXICO. IXICO is trading at a lower price-to-earnings ratio than C4X Discovery, indicating that it is currently the more affordable of the two stocks.
C4X Discovery has a beta of 0.23, suggesting that its share price is 77% less volatile than the S&P 500. Comparatively, IXICO has a beta of 0.86, suggesting that its share price is 14% less volatile than the S&P 500.
In the previous week, C4X Discovery's average media sentiment score of 0.00 equaled IXICO'saverage media sentiment score.
IXICO received 56 more outperform votes than C4X Discovery when rated by MarketBeat users. However, 77.88% of users gave C4X Discovery an outperform vote while only 71.64% of users gave IXICO an outperform vote.
C4X Discovery has a net margin of 42.81% compared to IXICO's net margin of -31.10%. C4X Discovery's return on equity of 55.38% beat IXICO's return on equity.
Summary
C4X Discovery beats IXICO on 8 of the 12 factors compared between the two stocks.
Get IXICO News Delivered to You Automatically
Sign up to receive the latest news and ratings for IXI and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
This page (LON:IXI) was last updated on 4/20/2025 by MarketBeat.com Staff
